Your browser doesn't support javascript.
loading
GAL3 receptor KO mice exhibit an anxiety-like phenotype.
Brunner, Susanne M; Farzi, Aitak; Locker, Felix; Holub, Barbara S; Drexel, Meinrad; Reichmann, Florian; Lang, Andreas A; Mayr, Johannes A; Vilches, Jorge J; Navarro, Xavier; Lang, Roland; Sperk, Günther; Holzer, Peter; Kofler, Barbara.
Afiliación
  • Brunner SM; Laura Bassi Centre of Expertise-Therapeutic Application of Neuropeptides (THERAPEP), Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, and.
  • Farzi A; Research Unit of Translational Neurogastroenterology, Institute of Experimental and Clinical Pharmacology, Medical University of Graz, 8010 Graz, Austria;
  • Locker F; Laura Bassi Centre of Expertise-Therapeutic Application of Neuropeptides (THERAPEP), Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, and.
  • Holub BS; Laura Bassi Centre of Expertise-Therapeutic Application of Neuropeptides (THERAPEP), Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, and.
  • Drexel M; Department of Pharmacology, Medical University Innsbruck, 6020 Innsbruck, Austria; and.
  • Reichmann F; Research Unit of Translational Neurogastroenterology, Institute of Experimental and Clinical Pharmacology, Medical University of Graz, 8010 Graz, Austria;
  • Lang AA; Laura Bassi Centre of Expertise-Therapeutic Application of Neuropeptides (THERAPEP), Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, and.
  • Mayr JA; Laura Bassi Centre of Expertise-Therapeutic Application of Neuropeptides (THERAPEP), Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, and.
  • Vilches JJ; Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
  • Navarro X; Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
  • Lang R; Department of Dermatology, Paracelsus Medical University, 5020 Salzburg, Austria;
  • Sperk G; Department of Pharmacology, Medical University Innsbruck, 6020 Innsbruck, Austria; and.
  • Holzer P; Research Unit of Translational Neurogastroenterology, Institute of Experimental and Clinical Pharmacology, Medical University of Graz, 8010 Graz, Austria; peter.holzer@medunigraz.at b.kofler@salk.at.
  • Kofler B; Laura Bassi Centre of Expertise-Therapeutic Application of Neuropeptides (THERAPEP), Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, and peter.holzer@medunigraz.at b.kofler@salk.at.
Proc Natl Acad Sci U S A ; 111(19): 7138-43, 2014 May 13.
Article en En | MEDLINE | ID: mdl-24782539
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de Ansiedad / Receptor de Galanina Tipo 3 / Trastorno Depresivo Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de Ansiedad / Receptor de Galanina Tipo 3 / Trastorno Depresivo Límite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos